Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention
- DOI
- 10.1186/s10194-026-02434-8
- Published
- 2026-06-20
- Container
- The Journal of Headache and Pain
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s10194-026-02434-8,
title = {Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention},
author = {Simona Guerzoni and Lanfranco Pellesi and Lisa Giannessi and Flavia Lo Castro and Maria Chiara Olivieri and Luca Degli Esposti and Francesca Gandolfi},
year = {2026},
journal = {The Journal of Headache and Pain},
doi = {10.1186/s10194-026-02434-8},
url = {https://doi.org/10.1186/s10194-026-02434-8}
}RIS
TY - JOUR TI - Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention AU - Simona Guerzoni AU - Lanfranco Pellesi AU - Lisa Giannessi AU - Flavia Lo Castro AU - Maria Chiara Olivieri AU - Luca Degli Esposti AU - Francesca Gandolfi PY - 2026 JO - The Journal of Headache and Pain DO - 10.1186/s10194-026-02434-8 UR - https://doi.org/10.1186/s10194-026-02434-8 ER -
APA
Guerzoni, S., Pellesi, L., Giannessi, L., Castro, F. L., Olivieri, M. C., Esposti, L. D., & Gandolfi, F. (2026). Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention. The Journal of Headache and Pain. https://doi.org/10.1186/s10194-026-02434-8
Source records
- crossref · retrieved 2026-09-26T19:45:42.284Z